Genome Surveillance
San Francisco
About Genome Surveillance
DNA sequencing is driving the new genomic revolution but it’s currently bottlenecked with high compute costs and inaccuracies. Genome Surveillance is revolutionizing DNA sequencing to make it ten times faster and more accurate through reducing the heavy computational load and dropping it to a fraction of the cost of current technologies.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Seed (Feb 2016)
- Website: genomesurveillance.com
Industries & Categories
Biotechnology, Genetics, Health Care, Medical
Canonical: https://fsome.com/organization/genome-surveillance-2779450 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.